The Knowledge Management Center for Illuminating the Druggable Genome (KMC-IDG) at Mount Sinai will assemble, organize and visualize data collected from the under-studied druggable genome from the four families: protein kinases, nuclear receptor, ion channels and GPCRs. The KMC-IDG will also attempt linking such under-studied druggable targets for their potential applications in various diseases. To achieve this we will assemble and abstract data from four domains: proteins/genes/targets, drugs/perturbagens, diseases/phenotypes/side-effects, and data from individual patients. Various pipe-lines and workflow will be established to connect clusters of patients from various diseases to under-studied druggable targets. The Ma'ayan and Dudley Labs are well positioned to carry out successfully this project based on their prior track record of productivity, foundation of source code and data that is already collected and organized, and strong existing user base that can be directed to the newly developed portal. In addition, both labs have a strong track record of collaborations including the computational identification and experimental validation of at least one under-studied protein kinase as a potential important target for attenuating kidney fibrosis. One unique and innovative research component of this project is an investigation into the sources of the literature and experimental biases that exist in the molecular and cellular biology research domains.
The large amount of data that is accumulating from genome-wide emerging biotechnologies is illuminating new biology about many genes that until recently not much data was available. This new knowledge, integrated with existing databases, can be used to prioritize potential genes/proteins as novel drug targets.
|Hodos, Rachel; Zhang, Ping; Lee, Hao-Chih et al. (2018) Cell-specific prediction and application of drug-induced gene expression profiles. Pac Symp Biocomput 23:32-43|
|Shameer, Khader; Glicksberg, Benjamin S; Hodos, Rachel et al. (2018) Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning. Brief Bioinform 19:656-678|
|Torre, Denis; Lachmann, Alexander; Ma'ayan, Avi (2018) BioJupies: Automated Generation of Interactive Notebooks for RNA-Seq Data Analysis in the Cloud. Cell Syst 7:556-561.e3|
|Torre, Denis; Krawczuk, Patrycja; Jagodnik, Kathleen M et al. (2018) Datasets2Tools, repository and search engine for bioinformatics datasets, tools and canned analyses. Sci Data 5:180023|
|Oprea, Tudor I; Bologa, Cristian G; Brunak, Søren et al. (2018) Unexplored therapeutic opportunities in the human genome. Nat Rev Drug Discov 17:317-332|
|Guo, Yiqing; Pace, Jesse; Li, Zhengzhe et al. (2018) Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease. J Am Soc Nephrol 29:2529-2545|
|Wang, Zichen; Lachmann, Alexander; Keenan, Alexandra B et al. (2018) L1000FWD: fireworks visualization of drug-induced transcriptomic signatures. Bioinformatics 34:2150-2152|
|Koplev, Simon; Lin, Katie; Dohlman, Anders B et al. (2018) Integration of pan-cancer transcriptomics with RPPA proteomics reveals mechanisms of epithelial-mesenchymal transition. PLoS Comput Biol 14:e1005911|
|Lachmann, Alexander; Torre, Denis; Keenan, Alexandra B et al. (2018) Massive mining of publicly available RNA-seq data from human and mouse. Nat Commun 9:1366|
|Smith, Milo R; Yevoo, Priscilla; Sadahiro, Masato et al. (2018) Integrative bioinformatics identifies postnatal lead (Pb) exposure disrupts developmental cortical plasticity. Sci Rep 8:16388|
Showing the most recent 10 out of 66 publications